Answers are grounded in this paper and cite their sources.
BACKGROUNDGrowing evidence implicates the microbiota in pancreatic ductal adenocarcinoma (PDAC) pathogenesis; however, prior studies have predominantly focused on gut and oral niches.The role of biliary microbiota, located in close anatomical proximity to the pancreas, and its metabolic crosstalk with tumor cells remain largely unexplored.AIM To comprehensively characterize the biliary microbiome and metabolome in PDAC and to functionally elucidate how microbiota-associated α-tocopherol (α-Toc) suppresses PDAC cell proliferation through the G protein subunit γ10 (GNG10)mediated phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)-p21 signaling axis.METHODS Bile samples from PDAC patients and choledocholithiasis controls were collected by endoscopic retrograde cholangiopancreatography, profiled by 16S rRNA sequencing and untargeted metabolomics, then functionally validated in Capan-2 and MIA PaCa-2 cell lines, a subcutaneous xenograft model, and matched human PDAC tissues.The antiproliferative effects of α-Toc via cell cycle arrest were rigorously characterized through transcriptome sequencing, targeted GNG10 silencing, and complementary in vitro, in vivo, and histopathological assays.RESULTS PDAC patients harbored a distinct biliary microbial signature characterized by Turicibacter, Lautropia, Eikenella, Campylobacter, Haemophilus, Actinomyces, Slackia, and Brevibacterium (linear discriminant analysis > 2.0), which translated into a diagnostic classifier with robust performance for PDAC detection (area under the curve = 4 / 40 0.825).PDAC bile exhibited global metabolic remodeling, defined by 17 upregulated and 162 downregulated metabolites (P < 0.05).Orthogonal partial least-squares discrimination analysis (R²Y = 0.922, Q² = 0.589) and random forest modeling (out-ofbag error rate = 7.69%) confirmed discrimination of PDAC from controls based on the differential metabolites.Integrated multi-omics analyses identified α-Toc as the leading microbiota-associated metabolite depleted in PDAC (P < 0.05).The α-Toc markedly suppressed PDAC cell proliferation in vitro (P < 0.05).Transcriptomic profiling following α-Toc treatment identified the PI3K/AKT pathway as the most significantly enriched signaling cascade, with GNG10 as the top upregulated transcript.Concurrently, α-Toc dephosphorylated PI3K and AKT, upregulated p21, and induced G0/G1 cell cycle arrest (P < 0.05).The small interfering RNA-mediated GNG10 knockdown abolished these effects.Consistent findings were observed in preliminary experiments using the xenograft model and human PDAC tissues.CONCLUSION This study suggests a microbiota-based diagnostic framework for PDAC and indicates that biliary microbiota-associated metabolites may modulate tumorigenesis, thereby identifying a candidate axis warranting further investigation for microbiota-targeted intervention.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: